Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 6.67% is 183% above its 5-year average of -8.04%, near the high end of its 5-year range (-51.08%–24.42%).
8.06% below its 12-month average of 7.25%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.35%.
OPERATING MARGIN
6.67%
OPERATING MARGIN AVG TTM
7.25%
OPERATING MARGIN AVG 3Y
4.62%
OPERATING MARGIN AVG 5Y
-8.04%
OPERATING MARGIN AVG 10Y
-33.99%
OPERATING MARGIN AVG 15Y
-37.36%
OPERATING MARGIN AVG 20Y
-31.44%
CURRENT VS TTM AVG
-8.06%
CURRENT VS 3Y AVG
+44.26%
CURRENT VS 5Y AVG
+182.97%
CURRENT VS 10Y AVG
+119.63%
CURRENT VS 15Y AVG
+117.85%
CURRENT VS 20Y AVG
+121.22%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 747 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Niagen Bioscience Inc
Market Cap
$214.51M
Operating Margin
6.67%
TTM Avg
7.25%
3Y Avg
4.62%
5Y Avg
-8.04%
Market Cap
$214.35M
Operating Margin
-861.33%
TTM Avg
-1428.62%
3Y Avg
-714.31%
5Y Avg
-476.21%
Market Cap
$215.07M
Operating Margin
66.70%
TTM Avg
45.54%
3Y Avg
40.90%
5Y Avg
43.81%
Market Cap
$212.27M
Operating Margin
40.94%
TTM Avg
-5.20%
3Y Avg
-130.22%
5Y Avg
-446.71%
Market Cap
$217.34M
Operating Margin
-692.83%
TTM Avg
-418.51%
3Y Avg
-274.13%
5Y Avg
-339.94%
Market Cap
$218.26M
Operating Margin
-566038.89%
TTM Avg
-577080.92%
3Y Avg
-336097.22%
5Y Avg
-224856.35%
Market Cap
$209.49M
Operating Margin
-3099.93%
TTM Avg
-1606.37%
3Y Avg
-882.98%
5Y Avg
-646.62%
Market Cap
$209.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$221.87M
Operating Margin
28.94%
TTM Avg
-2955.01%
3Y Avg
-29613.43%
5Y Avg
-19789.03%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niagen Bioscience Inc (NAGE) | $214.51M | 6.67% | 7.25% | 4.62% | -8.04% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.35M | -861.33% | -1428.62% | -714.31% | -476.21% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $215.07M | 66.70% | 45.54% | 40.90% | 43.81% |
| Compugen Ltd. (CGEN)vs › | $212.27M | 40.94% | -5.20% | -130.22% | -446.71% |
| Alector, Inc. (ALEC)vs › | $217.34M | -692.83% | -418.51% | -274.13% | -339.94% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $218.26M | -566038.89% | -577080.92% | -336097.22% | -224856.35% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $209.49M | -3099.93% | -1606.37% | -882.98% | -646.62% |
| Sionna Therapeutics, Inc. (SION)vs › | $209.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Keros Therapeutics, Inc. (KROS)vs › | $221.87M | 28.94% | -2955.01% | -29613.43% | -19789.03% |
| Pro-Dex, Inc. (PDEX)vs › | $206.04M | 16.75% | 16.40% | 14.66% | 13.83% |
Gross Margin
64.2%
Operating Margin
6.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 2.35% |
| 2026-03-31 | 5.01% |
| 2025-12-31 | 6.21% |
| 2025-09-30 | 12.46% |
| 2025-06-30 | 10.24% |
| 2025-03-31 | 15.66% |
| 2024-12-31 | 24.42% |
| 2024-09-30 | 6.26% |
| 2024-06-30 | -1.13% |
| 2024-03-31 | -3.30% |
| 2023-12-31 | -0.79% |
| 2023-09-30 | -5.88% |
| 2023-06-30 | -11.40% |
| 2023-03-31 | -8.72% |
| 2022-12-31 | -6.88% |
| 2022-09-30 | -17.96% |
| 2022-06-30 | -38.17% |
| 2022-03-31 | -44.80% |
| 2021-12-31 | -29.93% |
| 2021-09-30 | -51.08% |
| 2021-06-30 | -31.38% |
| 2021-03-31 | -50.14% |
| 2020-12-31 | -39.37% |
| 2020-09-30 | -29.59% |
| 2020-06-30 | -24.12% |
| 2020-03-31 | -41.06% |
| 2019-12-31 | -67.69% |
| 2019-09-30 | -57.15% |
| 2019-06-30 | -64.68% |
| 2019-03-31 | -83.32% |
| 2018-12-31 | -90.88% |
| 2018-09-30 | -105.86% |
| 2018-06-30 | -101.72% |
| 2018-03-31 | -127.90% |
| 2017-12-31 | -116.56% |
| 2017-09-30 | -52.20% |
| 2017-06-30 | -62.83% |
| 2017-03-31 | -52.64% |
| 2016-12-31 | -37.64% |
| 2016-09-30 | -23.47% |
| 2016-06-30 | 4.20% |
| 2016-03-31 | 6.19% |
| 2015-12-31 | -28.43% |
| 2015-09-30 | 2.82% |
| 2015-06-30 | -3.02% |
| 2015-03-31 | -17.22% |
| 2014-12-31 | -26.01% |
| 2014-09-30 | -15.64% |
| 2014-06-30 | -42.57% |
| 2014-03-31 | -59.81% |
| 2013-12-31 | -29.78% |
| 2013-09-30 | -45.68% |
| 2013-06-30 | -37.43% |
| 2013-03-31 | -60.67% |
| 2012-12-31 | -48.05% |
| 2012-09-30 | -42.17% |
| 2012-06-30 | -149.31% |
| 2012-03-31 | -247.89% |
| 2011-12-31 | -137.39% |
| 2011-09-30 | -131.20% |
| 2011-06-30 | -94.68% |
| 2011-03-31 | -45.21% |
| 2010-12-31 | -43.77% |
| 2010-09-30 | -55.92% |
| 2010-06-30 | -14.42% |
| 2010-03-31 | 2.03% |
| 2009-12-31 | -7.20% |
| 2009-09-30 | -12.12% |
| 2009-06-30 | -21.37% |
| 2009-03-31 | -22.13% |
| 2008-12-31 | -53.32% |
| 2008-09-30 | -65.33% |
| 2008-06-30 | -52.21% |
| 2008-02-29 | 0.00% |
| 2007-11-30 | 0.00% |
| 2007-08-31 | 0.00% |
| 2007-05-31 | 0.00% |
| 2007-02-28 | 0.00% |
